Initial Management of Otitis Media with Effusion (OME)
Assessment and Documentation
- The American Academy of Family Physicians and the American Academy of Otolaryngology-Head and Neck Surgery recommend documenting the laterality, duration of effusion, and presence and severity of associated symptoms at each assessment 1, 4
- The American Academy of Otolaryngology-Head and Neck Surgery distinguishes children at risk for speech, language, or learning problems from other children with OME, as they require more prompt evaluation 2, 5
Initial Management Algorithm
- For non-risk children, the American Academy of Family Physicians recommends watchful waiting for 3 months from effusion onset or diagnosis, as approximately 75-90% of residual OME resolves spontaneously within this period 6, 3
- The American Academy of Otolaryngology-Head and Neck Surgery suggests that this period of observation carries little harm compared to unnecessary interventions 2, 3
- For at-risk children, the American Academy of Otolaryngology-Head and Neck Surgery recommends more prompt evaluation of hearing, speech, language, and need for intervention 2, 5
Medications to Avoid
- The American Academy of Family Physicians and the American Academy of Otolaryngology-Head and Neck Surgery recommend avoiding antihistamines and decongestants, as they are ineffective for OME 4, 3
- The American Academy of Family Physicians and the American Academy of Otolaryngology-Head and Neck Surgery also recommend avoiding antimicrobials, as they do not have long-term efficacy and may have adverse effects 4, 3
Follow-up Management
- The American Academy of Family Physicians recommends re-examining children with persistent OME at 3-6 month intervals until the effusion resolves, significant hearing loss is identified, or structural abnormalities are suspected 8, 7
Surgical Considerations
- The American Academy of Family Physicians recommends tympanostomy tube insertion as the preferred initial surgical procedure when a child becomes a surgical candidate 8, 9
- Surgical candidates include children with OME lasting 4 months or longer with persistent hearing loss or other signs/symptoms, recurrent or persistent OME in at-risk children, or OME with structural damage to the tympanic membrane or middle ear 8